3654 results for «397»
3654 results
Mitral valve TEER echocardiography
29 Sep 2025 – From PCR Gulf Valves 2025
Gain essential knowledge in mitral valve TEER echocardiography through this comprehensive session focused on key echocardiographic views, image optimization for screening, criteria for suitability, and intraprocedural guidance. Enhance your skills with practical hands-on components aimed at improving procedural outcomes.
Prediction and prevention of coronary artery obstruction during TAVI
29 Sep 2025 – From PCR Gulf Valves 2025
This session delivers expert insights into predicting and preventing coronary artery obstruction during TAVI procedures. Attendees will learn comprehensive assessment strategies for both native and bioprosthetic valves and explore advanced techniques to minimize occlusion risk in high-risk patients, including discussion of the UNICORN approach.
Advanced mitral valve TEER echocardiography
29 Sep 2025 – From PCR Gulf Valves 2025
Delve into advanced echocardiographic techniques for mitral valve TEER in this session. Gain expert knowledge on transseptal access, managing complex anatomical challenges, and practical strategies to navigate difficult and high-risk TEER procedures effectively.
Hot topics: complex structural cases on mitral stenosis, alternative access and electrosurgery
29 Sep 2025 – From PCR Gulf Valves 2025
This session highlights cutting-edge approaches to complex structural heart cases, including mitral stenosis management via balloon valvuloplasty, alternative access methods such as transcaval TAVI, and innovative solutions for failed mitral TEER procedures, providing comprehensive technical insights and case resolutions.
CT assessment for TAVI
29 Sep 2025 – From PCR Gulf Valves 2025
This educational session focuses on the critical role of CT angiography in TAVI planning. Attendees will learn to identify key anatomical landmarks, perform accurate measurements, and interpret imaging data to optimize patient selection and procedural success through a multimodal approach.
Tricuspid transcatheter therapies: the game changer
29 Sep 2025 – From PCR Gulf Valves 2025
Explore the evolving landscape of tricuspid transcatheter therapies in this comprehensive session reviewing tricuspid regurgitation etiology, anatomy, and current treatment options. Learn about various transcatheter tricuspid valve intervention devices, their strengths and limitations, and the critical diagnostic and intraprocedural imaging requirements to optimize patient selection and...
Redefining standards: TAVI in the era of lifetime management, beyond high-risk patients
29 Sep 2025 – From PCR Gulf Valves 2025
Discover a selection of cases showcasing the key features of the Navitor Valve System and its clinical applications. This session explores auxiliary access, the use of Navitor in alternative access and complex PCI, its performance in challenging peripheral anatomies, and innovative outcomes with the Vantage 30D...
Clinical cases
29 Sep 2025 – From PCR Gulf Valves 2025
This session presents challenging clinical cases focusing on post-TAVI paravalvular leakage and the percutaneous closure of paravalvular leaks following surgically implanted Intuity valves. Gain valuable insights into complex management strategies and procedural techniques addressing these complications.
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial
07 Nov 2022
Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation.
Author
IMPELLA supported PCI via a single access sheath - Introduction and rapid adoption: the Power of Social Media
22 Dec 2020
This manuscript examines Impella single access technique, which provides a case example of the central role social media can play in the introduction of a new interventional approach.
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation
05 Sep 2023
Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.
Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...
Author
The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030
29 Aug 2021
Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.
Author
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)
08 Apr 2024
Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.
Author
